285 related articles for article (PubMed ID: 12056554)
1. Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists.
Ksander GM; Shetty SS; DelGrande D; Balwierczak JL; Bruseo CW; Savage P; deJesus R; Yuan A; Webb RL; Jeng AY
Can J Physiol Pharmacol; 2002 May; 80(5):464-9. PubMed ID: 12056554
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a potent and selective endothelin-B receptor antagonist, IRL 2500.
Balwierczak JL; Bruseo CW; DelGrande D; Jeng AY; Savage P; Shetty SS
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S393-6. PubMed ID: 8587424
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems.
Henry PJ
Br J Pharmacol; 1993 Sep; 110(1):435-41. PubMed ID: 8220905
[TBL] [Abstract][Full Text] [Related]
4. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
Hay DW; Luttmann MA; Beck G; Ohlstein EH
Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the binding of endothelin ETB selective ligands in human and rat heart.
Russell FD; Davenport AP
Br J Pharmacol; 1996 Oct; 119(4):631-6. PubMed ID: 8904635
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083.
Douglas SA; Nambi P; Gellai M; Luengo JI; Xiang JN; Brooks DP; Ruffolo RR; Elliott JD; Ohlstein EH
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S273-6. PubMed ID: 9595458
[TBL] [Abstract][Full Text] [Related]
7. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
Nishikibe M; Ohta H; Okada M; Ishikawa K; Hayama T; Fukuroda T; Noguchi K; Saito M; Kanoh T; Ozaki S; Kamei T; Hara K; William D; Kivlighn S; Krause S; Gabel R; Zingaro G; Nolan N; O'Brien J; Clayton F; Lynch J; Pettibone D; Siegl P
J Pharmacol Exp Ther; 1999 Jun; 289(3):1262-70. PubMed ID: 10336515
[TBL] [Abstract][Full Text] [Related]
9. Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.
Buchan KW; Alldus C; Christodoulou C; Clark KL; Dykes CW; Sumner MJ; Wallace DM; White DG; Watts IS
Br J Pharmacol; 1994 Aug; 112(4):1251-7. PubMed ID: 7952888
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.
Nambi P; Pullen M; Kincaid J; Nuthulaganti P; Aiyar N; Brooks DP; Gellai M; Kumar C
Mol Pharmacol; 1997 Oct; 52(4):582-9. PubMed ID: 9380020
[TBL] [Abstract][Full Text] [Related]
11. Ca2+ signalling by endothelin receptors in rat and human cultured airway smooth muscle cells.
Maxwell MJ; Goldie RG; Henry PJ
Br J Pharmacol; 1998 Dec; 125(8):1768-78. PubMed ID: 9886769
[TBL] [Abstract][Full Text] [Related]
12. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
Warner TD; Allcock GH; Corder R; Vane JR
Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
[TBL] [Abstract][Full Text] [Related]
13. Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors.
Iglarz M; Steiner P; Wanner D; Rey M; Hess P; Clozel M
J Cardiovasc Pharmacol; 2015 Oct; 66(4):332-7. PubMed ID: 25992919
[TBL] [Abstract][Full Text] [Related]
14. Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.
Ohlstein EH; Nambi P; Hay DW; Gellai M; Brooks DP; Luengo J; Xiang JN; Elliott JD
J Pharmacol Exp Ther; 1998 Aug; 286(2):650-6. PubMed ID: 9694916
[TBL] [Abstract][Full Text] [Related]
15. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries.
Mickley EJ; Gray GA; Webb DJ
Br J Pharmacol; 1997 Apr; 120(7):1376-82. PubMed ID: 9105715
[TBL] [Abstract][Full Text] [Related]
16. ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction.
LaDouceur DM; Flynn MA; Keiser JA; Reynolds E; Haleen SJ
Biochem Biophys Res Commun; 1993 Oct; 196(1):209-15. PubMed ID: 8216294
[TBL] [Abstract][Full Text] [Related]
17. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.
Maguire JJ; Davenport AP
Br J Pharmacol; 1995 May; 115(1):191-7. PubMed ID: 7647976
[TBL] [Abstract][Full Text] [Related]
18. Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors.
Willette RN; Sauermelch CF; Storer BL; Guiney S; Luengo JI; Xiang JN; Elliott JD; Ohlstein EH
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S149-57. PubMed ID: 9595425
[TBL] [Abstract][Full Text] [Related]
19. Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi.
Fukuroda T; Ozaki S; Ihara M; Ishikawa K; Yano M; Miyauchi T; Ishikawa S; Onizuka M; Goto K; Nishikibe M
Br J Pharmacol; 1996 Mar; 117(6):995-9. PubMed ID: 8882588
[TBL] [Abstract][Full Text] [Related]
20. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
Ohlstein EH; Nambi P; Lago A; Hay DW; Beck G; Fong KL; Eddy EP; Smith P; Ellens H; Elliott JD
J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
